Actively Recruiting

Phase 4
Age: 18Years - 80Years
All Genders
NCT04729686

The Pericapsular Nerve Block in Total Hip Arthroplasty

Led by LifeBridge Health · Updated on 2025-01-22

78

Participants Needed

1

Research Sites

259 weeks

Total Duration

On this page

Sponsors

L

LifeBridge Health

Lead Sponsor

R

Rubin Institute for Advanced Orthopedics

Collaborating Sponsor

AI-Summary

What this Trial Is About

In order to continue progressing towards outpatient total hip arthroplasty (THA), methods to adequately manage postoperative pain is of paramount importance. The purpose of this study is to quantify the effectiveness of the pericapsular nerve block in total hip arthroplasty in comparison to the fascia iliaca nerve block.

CONDITIONS

Official Title

The Pericapsular Nerve Block in Total Hip Arthroplasty

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Signed and dated informed consent form
  • Willingness to comply with all study procedures and availability for the duration of the study
  • Planned primary total hip arthroplasty with anterior (Smith-Peterson) approach
  • ASA score of 1 to 3
  • Indicated for one of the two nerve block groups
  • Opioid naive at screening as defined by the FDA (not taking opioids at specified doses for one week or longer)
Not Eligible

You will not qualify if you...

  • Current or previous diagnosis of chronic pain
  • Opioid tolerant at time of screening (using opioids at or above specified doses for one week or longer)
  • Diagnosis of ankylosing spondylitis
  • Allergy to any medications used in the nerve block groups
  • Conversion to general anesthesia during surgery
  • Treatment with another investigational drug or intervention for pain
  • Any physical or psychological condition or exam finding that would prevent participation according to the investigator

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Sinai Hospital of Baltimore

Baltimore, Maryland, United States, 21215

Actively Recruiting

Loading map...

Research Team

M

Martin Gesheff

CONTACT

N

Nirav Patel

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here